Rapamycin preferentially inhibits human IL-5+ TH2-cell proliferation via an mTORC1/S6 kinase-1-dependent pathway.
about
An optimized protocol for the generation and functional analysis of human mast cells from CD34+ enriched cell populations.Pathogenic Effector Th2 Cells in Allergic Eosinophilic Inflammatory Disease.Astragaloside IV Ameliorates Airway Inflammation in an Established Murine Model of Asthma by Inhibiting the mTORC1 Signaling Pathway.
P2860
Rapamycin preferentially inhibits human IL-5+ TH2-cell proliferation via an mTORC1/S6 kinase-1-dependent pathway.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Rapamycin preferentially inhib ...... S6 kinase-1-dependent pathway.
@en
type
label
Rapamycin preferentially inhib ...... S6 kinase-1-dependent pathway.
@en
prefLabel
Rapamycin preferentially inhib ...... S6 kinase-1-dependent pathway.
@en
P2093
P1476
Rapamycin preferentially inhib ...... S6 kinase-1-dependent pathway.
@en
P2093
Daniel L Wansley
Satya P Singh
P304
1701-1704.e10
P356
10.1016/J.JACI.2016.10.029
P407
P577
2016-12-03T00:00:00Z